Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

30.40 +0.57 (+1.91%)
Streaming Delayed Price Updated: 1:17 PM EDT, Aug 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 150,076
Open 29.98
Bid (Size) 30.39 (1)
Ask (Size) 30.42 (2)
Prev. Close 29.83
Today's Range 29.93 - 30.80
52wk Range 20.39 - 53.95
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): A Value Stock with Strong Fundamentals and Undervalued Potential
Amphastar Pharmaceuticals (AMPH) offers strong value potential with low P/E ratios, high profitability, and stable finances, making it a solid pick for value investors seeking undervalued stocks. 
Via Chartmill
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Lawsuit

Performance

YTD
-16.4%
-16.4%
1 Month
+36.7%
+36.7%
3 Month
+19.1%
+19.1%
6 Month
-5.9%
-5.9%
1 Year
-36.9%
-36.9%

More News

Read More
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
Via ACCESS Newswire
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
Via ACCESS Newswire
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q2 Sales Targets, But Stock Soars 6%
Via StockStory
Amphastar (AMPH) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Supply Chain
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
Via ACCESS Newswire
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Find Risky
Via StockStory
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
Via ACCESS Newswire
3 Low-Volatility Stocks with Questionable Fundamentals
Via StockStory
Topics Supply Chain
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know
Via StockStory
Topics Stocks World Trade
agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know
Via StockStory
Topics Lawsuit World Trade
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters
Via ACCESS Newswire
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know
Via StockStory
Topics ETFs Stocks World Trade
1 Healthcare Stock on Our Buy List and 2 to Approach with Caution
Via StockStory
Topics Stocks
AMPHASTAR PHARMACEUTICALS INC (NASDAQ:AMPH) – An Undervalued Stock Worth Considering
Via Chartmill
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore
Via StockStory
Topics Stocks
3 Value Stocks with Questionable Fundamentals
Via StockStory
AMPHASTAR PHARMACEUTICALS INC (NASDAQ:AMPH) – An Undervalued Stock Worth Considering
Via Chartmill
3 Russell 2000 Stocks with Questionable Fundamentals
Via StockStory
3 Small-Cap Stocks Walking a Fine Line
Via StockStory
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know
Via StockStory
Topics Artificial Intelligence Government Stocks
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 30.40
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 08/26/25 01:17 PM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 1.46B
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.